IQST vs RARE · rev $207.0M vs rev $350.0M
Iqstel Inc (IQST) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Iqstel Inc (IQST) is a telecom services company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported IQST revenue for 2026-06-30 was $207.0M. Net income was -$3.8M. IQST currently screens at market cap $6.5M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
IQST currently screens at market cap $6.5M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the IQST and RARE stock pages for the full models.
Not investment advice.